Stock 8432 TSH BIOPHARM CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : TSH Biopharm Corporation Limited

TSH Biopharm Corporation Limited Stock price

Equities

8432

TW0008432006

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2023-12-07 pm EST 		Intraday chart for TSH Biopharm Corporation Limited 5-day change 1st Jan Change
48.9 TWD -0.41% -4.12% +2.84%
Nov. 02 TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Aug. 04 TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Financials

Sales 2022 464M 14.78M Sales 2023 * - Capitalization 1.83B 58.13M
Net income 2022 61M 1.94M Net income 2023 * - EV / Sales 2022
2,38x
Net cash position 2022 722M 22.99M Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022
29,5x
P/E ratio 2023 *
Employees 76
Yield 2022
3,36%
Yield 2023 *
-
Free-Float 35.47%
More Fundamentals * Assessed data

Chart TSH Biopharm Corporation Limited

Dynamic Chart

Latest news about TSH Biopharm Corporation Limited

TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members CI
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
TSH Biopharm Corporation Limited Announces Board Appointments CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
TSH Biopharm Corporation Limited Appoints Yaw-Bin, Huang as Audit Committee Member CI
TSH Biopharm Corporation Limited Announces Cash Dividends, Payable on July 8, 2022 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
TSH Biopharm Corporation Limited Announces Resignation of Yi-Min Wang from Audit Committee and Remuneration Committee CI
More news

Press releases TSH Biopharm Corporation Limited

TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities PU
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022 PU
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee PU
TSH Biopharm : was invited to attend the online institutional investor conference hosted by Concord Securities PU
TSH Biopharm : Announcement of Change to Remuneration Committee member PU
More press releases

Quotes and Performance

1 day-0.41%
1 week-4.12%
Current month-3.74%
1 month-13.30%
3 months+5.50%
6 months+7.00%
Current year+2.84%
More quotes

Highs and lows

1 week
48.90
Extreme 48.9
51.80
1 month
48.80
Extreme 48.8
56.60
Current year
44.15
Extreme 44.15
60.10
1 year
44.15
Extreme 44.15
60.10
3 years
38.80
Extreme 38.8
61.50
5 years
38.80
Extreme 38.8
82.50
10 years
34.95
Extreme 34.95
114.50
More quotes

Managers and Directors - TSH Biopharm Corporation Limited

Managers TitleAgeSince
Ssu Yuan Yang CEO
 Chief Executive Officer - -
Chen Ju Kan DFI
 Director of Finance/CFO - 2010
Shu Ping Huang ADM
 Chief Administrative Officer - 2010
Members of the board TitleAgeSince
Kang Chi Chou BRD
 Director/Board Member - -
Chuan Lin CHM
 Chairman 71 -
Hsin Yang Liu PRN
 Corporate Officer/Principal - -
More insiders

Quotes

Date Price Change Volume
23-12-08 48.9 -0.41% 81,552
23-12-07 49.1 -0.41% 137,258
23-12-06 49.3 -1.20% 158,549
23-12-05 49.9 -2.54% 178,314
23-12-04 51.2 +0.39% 162,277

End-of-day quote Taipei Exchange, December 07, 2023

More quotes

Company Profile

Tsh biopham corporation ltd. is a Taiwan-based company principally engaged in the manufacturing and distribution of medical preparations. The Company primarily provides medicines for cardiovascular, including Amtrel, Rytmonorm, Licodin, Isormol and ISOPTIN SR; medicines for intestines and stomach, including MOPRIDE, Catilon, Gastro-Timelet and Ribarin, and medicines for central nervous, including Aleviatin, Lonine and Lacoxa SR. The Company distributes its products mainly in domestic markets.
Sector
Pharmaceuticals
Calendar
2024-02-29 - Q4 2023 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

1st Jan change Capi.
TSH BIOPHARM CORPORATION LIMITED Stock TSH Biopharm Corporation Limited
+2.84% 60 M $
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+63.47% 538 B $
NOVO NORDISK A/S Stock Novo Nordisk A/S
+42.56% 430 B $
JOHNSON & JOHNSON Stock Johnson & Johnson
-12.58% 372 B $
MERCK & CO., INC. Stock Merck & Co., Inc.
-6.49% 263 B $
ABBVIE INC. Stock AbbVie Inc.
-7.63% 264 B $
NOVARTIS AG Stock Novartis AG
+1.35% 198 B $
ASTRAZENECA PLC Stock AstraZeneca PLC
-9.77% 197 B $
PFIZER, INC. Stock Pfizer, Inc.
-43.83% 163 B $
AMGEN INC. Stock Amgen Inc.
+2.47% 144 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock TSH Biopharm Corporation Limited - Taipei Exchange
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer